Identification of Antifungal Targets Using Proteomics

使用蛋白质组学鉴定抗真菌靶点

基本信息

  • 批准号:
    6656801
  • 负责人:
  • 金额:
    $ 32.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-03-01 至 2006-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cryptococcus neoformans is an opportunistic fungal pathogen in patients with AIDS. C. neoformans is a basidiomycetes widely diverged from most other fungal pathogens. The most common clinical presentations are meningoencephalitis and pulmonary cryptococcosis. Available antifungal agents, directed against the ergosterol pathway, are inadequate for continued safe and effective therapy due to inherent toxicity, emerging fungal resistance, and the requirement for lifelong treatment. New targets for antifungal therapies are needed. Proteins that are differentially regulated during infection may be essential for pathogenesis and be good targets for novel antifungal therapies. Over the past decade, the pathogenesis of C. neoformans has been intensively studied using molecular biology, genetic, immunological and biochemical approaches. However, only a handful of new antifungal targets have been identified using traditional methods. A funded genome project for C. neoformans has made new approaches possible. We have developed a proteomic system for C. neoformans that utilizes 2-dimensional gel electrophoresis and MALDI-TOF analysis. We will reproducibly separate and quantitate proteins, identify proteins that are affected by specific conditions, and determine the identity of those proteins. We propose to use proteomics to identify C. neoformans proteins that are affected by specific in vitro conditions that mimic an aspect of the infection process. These proteins will form the basis for comparison for additional studies examining proteins that are affected in an animal model. The genes encoding these proteins will be mutated by targeted gene disruption and tested for their role in viability and pathogenesis using a mouse model.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jennifer K. Lodge其他文献

Immunological correlates of protection mediated by a whole organism, emCryptococcus neoformans/em, vaccine deficient in chitosan
壳聚糖缺陷的新型隐球菌全菌疫苗介导的保护性免疫相关因素
  • DOI:
    10.1128/mbio.01746-24
  • 发表时间:
    2024-07-26
  • 期刊:
  • 影响因子:
    4.700
  • 作者:
    Charles A. Specht;Ruiying Wang;Lorena V. N. Oliveira;Maureen M. Hester;Christina Gomez;Zhongming Mou;Diana Carlson;Chrono K. Lee;Camaron R. Hole;Woei C. Lam;Rajendra Upadhya;Jennifer K. Lodge;Stuart M. Levitz
  • 通讯作者:
    Stuart M. Levitz

Jennifer K. Lodge的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jennifer K. Lodge', 18)}}的其他基金

2014 Cellular and Molecular Fungal Biology Gordon Research Conference
2014年细胞与分子真菌生物学戈登研究会议
  • 批准号:
    8718564
  • 财政年份:
    2014
  • 资助金额:
    $ 32.53万
  • 项目类别:
A NOVEL SCREEN FOR ANTIFUNGALS THAT TARGET CHITOSAN BIOSYNTHESIS
针对壳聚糖生物合成的新型抗真菌药物筛选
  • 批准号:
    8545318
  • 财政年份:
    2012
  • 资助金额:
    $ 32.53万
  • 项目类别:
Chitosan in Cryptococcus
隐球菌中的壳聚糖
  • 批准号:
    7994194
  • 财政年份:
    2007
  • 资助金额:
    $ 32.53万
  • 项目类别:
Chitosan in Cryptococcus
隐球菌中的壳聚糖
  • 批准号:
    7883766
  • 财政年份:
    2007
  • 资助金额:
    $ 32.53万
  • 项目类别:
Chitosan in Cryptococcus
隐球菌中的壳聚糖
  • 批准号:
    7382612
  • 财政年份:
    2007
  • 资助金额:
    $ 32.53万
  • 项目类别:
Chitosan in Cryptococcus
隐球菌中的壳聚糖
  • 批准号:
    8761728
  • 财政年份:
    2007
  • 资助金额:
    $ 32.53万
  • 项目类别:
Chitosan in Cryptococcus
隐球菌中的壳聚糖
  • 批准号:
    7539928
  • 财政年份:
    2007
  • 资助金额:
    $ 32.53万
  • 项目类别:
Chitosan in Cryptococcus
隐球菌中的壳聚糖
  • 批准号:
    7739458
  • 财政年份:
    2007
  • 资助金额:
    $ 32.53万
  • 项目类别:
Identification of Antifungal Targets Using Proteomics
使用蛋白质组学鉴定抗真菌靶点
  • 批准号:
    6861054
  • 财政年份:
    2003
  • 资助金额:
    $ 32.53万
  • 项目类别:
Identification of Antifungal Targets Using Proteomics
使用蛋白质组学鉴定抗真菌靶点
  • 批准号:
    6701783
  • 财政年份:
    2003
  • 资助金额:
    $ 32.53万
  • 项目类别:

相似海外基金

SusChEM: Fungal Proteins as Agents for Organization and Delivery of Electroactive Materials
SusChEM:真菌蛋白作为电活性材料组织和传递的试剂
  • 批准号:
    1609058
  • 财政年份:
    2016
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Continuing Grant
Secreted fungal proteins in immune evasion and pathogenicity (C06)
分泌的真菌蛋白在免疫逃避和致病性中的作用(C06)
  • 批准号:
    239827919
  • 财政年份:
    2013
  • 资助金额:
    $ 32.53万
  • 项目类别:
    CRC/Transregios
CHARACTERIZATION OF RECOMBINANT FUNGAL PROTEINS
重组真菌蛋白的表征
  • 批准号:
    7602801
  • 财政年份:
    2007
  • 资助金额:
    $ 32.53万
  • 项目类别:
A constant cell disruption system for the extracton of mammalian bacterial and fungal proteins for structure-function relationship studies
用于提取哺乳动物细菌和真菌蛋白以进行结构-功能关系研究的恒定细胞破碎系统
  • 批准号:
    345542-2007
  • 财政年份:
    2006
  • 资助金额:
    $ 32.53万
  • 项目类别:
    Research Tools and Instruments - Category 1 (<$150,000)
CHARACTERIZATION OF RECOMBINANT FUNGAL PROTEINS
重组真菌蛋白的表征
  • 批准号:
    7359074
  • 财政年份:
    2006
  • 资助金额:
    $ 32.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了